The full cost of bringing a new drug to market from discovery, includes drug development through clinical trials to approval.
Typically, companies spend tens to hundreds of millions of U.S. dollars on drug development. But then tens of millions more must be spent on Phase 1 through 3 trials.
If the wrong product is delivered to a clinical trial testing site, or not delivered in a timely manner, it becomes a deviation which can trigger actions that lead to an extended trial period.
Running clinical trials without service deviations improves a products speed to market! And speed to market can be where the biggest savings from improved supply chain planning occurs.
Effective fulfillment can dwarf all other benefits of the supply chain. If an efficiently run clinical trial supply chain leads to a drug hitting the market one year earlier than it otherwise would have, this can lead to hundreds of millions in additional revenue.
Learn more about how client interface capabilities like BS3’s customised client portal have benefited pharmaceutical companies to safeguard clinical trial success: For Big Pharma, The Clinical Trials Supply Chain is Critical – Logistics Viewpoints
